The global antiseptic and disinfectant market is projected to experience substantial growth, reaching $61.2 billion by 2031. This expansion is driven by several factors, including the growing threat of antimicrobial resistance, the increasing prevalence of healthcare-associated infections, and the heightened awareness of hygiene practices sparked by the COVID-19 pandemic. The report highlights key market drivers, trends, and regional profiles, with North America emerging as a leading region due to its advanced healthcare infrastructure and stringent regulations.